Seneca Growth Capital VCT has 2 classes of share - ordinary and B shares. Please note that dividends paid by this fund are done so via the B share class.
Overview
Performance
Portfolio
Dividends
Charges
Research
Announcements
Management
Documents
Invest
Engage
Data as at: 25/04/2024
In
Objective
To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted AIM/AQSE UK companies which meet the relevant criteria under the VCT Rules.
AIC sector
Management group
Seneca Partners Limited
Company website
Launch date
19/04/2002
December
Domicile
United Kingdom
Fund manager
Not Disclosed
Dividend frequency
Semi-Annually
Wind-up provisions
The Directors are required by the articles of the association to propose an ordinary resolution at the Company's AGM in 2024 that the Company should continue as a VCT for a further three year period, and at three yearly intervals thereafter. If any such resolution is not passed, the Directors shall within four months convene a general meeting to consider the proposals for the reorganisation or winding up of the Company.
Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
---|---|---|---|---|---|---|---|---|
1.10 | 1.50 | 13.50 | 18.50 | -27.03 | N/A | 29.63 | Jun, Dec | 1.74 (31/12/2023) |
Scroll
Note
Dividends
Dividends declared in last 12 months
Ex-Dividend date | Payment date | Dividend amount | Special dividend | Financial year |
---|---|---|---|---|
04/05/2023 | 19/05/2023 | 2.000 | No | 2022 |
Scroll
Performance (%)
Return type | 1 year | 3 years | 5 years | 10 years | |
---|---|---|---|---|---|
Seneca Growth Capital VCT | Share price total return | -31.1 | -47.4 | 54.7 | 7.7 |
VCT Specialist: Healthcare & Biotechnology AIC sector | Share price total return | N/A | N/A | N/A | N/A |
Scroll
Share structure
Number of shares
8,115,376
Traded volumes (number of shares)
Yesterday | 1 month | 1 year | 5 years | |
---|---|---|---|---|
Total | 0 | 0 | 276,155 | 1,482,276 |
Average | N/A | N/A | 1,062 | 1,146 |
Scroll
Traded values (m)
Yesterday | 1 month | 1 year | 5 years | |
---|---|---|---|---|
Total | N/A | N/A | 0.04 | 0.35 |
Average | N/A | 0.00 | 0.00 | 0.00 |
Scroll
Trading details
Top holdings
Data as at : 30/06/2022
Investment | % of total assets |
---|---|
ImmunoBiology Limited | 25.1 |
OR Productivity Limited | 22.1 |
Scancell Holdings Plc | 19.2 |
Insense Limited | 14.7 |
Fuel 3D Technologies Limited | 8.6 |
Arecor Therapeutics Plc | 6.6 |
Microarray Limited | 3.8 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.